Literature DB >> 8201504

Palmar hyperhidrosis in children: treatment with video endoscopic laser sympathectomy.

M C Kao1, W Y Lee, K M Yip, Y Y Hsiao, Y S Lee, J C Tsai.   

Abstract

Palmar hyperhidrosis (PH) often starts in childhood and can be a disabling condition for a significant number of young children at the age they begin primary school. There are few reports regarding the surgical treatment of PH in children. The authors report on 40 PH patients under 16 years of age treated with video thoracoscopic laser sympathectomy; there has been substantial experience with this procedure for the treatment of adults with PH. A satisfactory result, with very low morbidity, was achieved for all 40 children. The surgical technique is described briefly. With the technique, the proper sympathetic segment is visualized in almost all cases and then definitely ablated with a fiberoptic low-power laser while under the aid of sympathetic monitoring. Consequently, an adequate sympathectomy warranting a long-lasting therapeutic effect can be achieved without the need of tissue diagnosis. No case required conversion to open sympathectomy. Neither injury to the lung nor bleeding was encountered. Horner's syndrome did not occur in any case. Bilateral sympathectomy was accomplished generally within 30 minutes. All patients were discharged after an overnight stay and are doing well with normal activities. The most frequent complication was compensatory hyperhidrosis, which was tolerable after reassurance. Based on the accumulated experience, it is justified to recommend early surgery, with this refined technique, in cases of severe PH in children.

Entities:  

Mesh:

Year:  1994        PMID: 8201504     DOI: 10.1016/0022-3468(94)90574-6

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  9 in total

Review 1.  Thoracoscopic sympathectomy for palmar hyperhidrosis. Ablate or resect?

Authors:  M Hashmonai; A Assalia; D Kopelman
Journal:  Surg Endosc       Date:  2001-04-03       Impact factor: 4.584

2.  Morphometric study of the upper thoracic sympathetic Ganglia.

Authors:  Sang Beom Lee; Jae Chil Chang; Sukh Que Park; Sung Jin Cho; Soon Kwan Choi; Hack Gun Bae
Journal:  J Korean Neurosurg Soc       Date:  2011-07-31

3.  Laparoscopic and thoracoscopic surgery in children and adolescents: a 3-year experience.

Authors:  Z Cohen; D Shinhar; E Kurzbart; R Finaly; A J Mares
Journal:  Pediatr Surg Int       Date:  1997-07       Impact factor: 1.827

Review 4.  Thoracic sympathectomy for hyperhidrosis: from surgical indications to clinical results.

Authors:  Fernando Vannucci; José Augusto Araújo
Journal:  J Thorac Dis       Date:  2017-04       Impact factor: 2.895

5.  Transthoracic endoscopic sympathectomy for primary palmar hyperhidrosis in children.

Authors:  H J Chen; T Y Shih; M H Cheng
Journal:  Pediatr Surg Int       Date:  2013-09-21       Impact factor: 1.827

Review 6.  The correlation between the method of sympathetic ablation for palmar hyperhidrosis and the occurrence of compensatory hyperhidrosis: a review.

Authors:  Doron Kopelman; Moshe Hashmonai
Journal:  World J Surg       Date:  2008-11       Impact factor: 3.352

7.  Thoracoscopic sympathectomy for palmar and axillary hyperhidrosis: four-year outcome and quality of life after bilateral 5-mm dual port approach.

Authors:  Kai Bachmann; Nicola Standl; Jussuf Kaifi; Phillip Busch; Eva Winkler; Oliver Mann; Jakob R Izbicki; Tim Strate
Journal:  Surg Endosc       Date:  2009-03-04       Impact factor: 4.584

8.  Results of thoracoscopic sympathectomy for the treatment of axillary and palmar hyperhidrosis with respect to compensatory hyperhidrosis and dry hands.

Authors:  M J Wilson; T R Magee; R B Galland; T C B Dehn
Journal:  Surg Endosc       Date:  2004-11-18       Impact factor: 4.584

9.  Over a decade of single-center experience with thoracoscopic sympathicolysis for primary palmar hyperhidrosis: a case series.

Authors:  Adam Mol; Oliver J Muensterer
Journal:  Surg Endosc       Date:  2020-07-08       Impact factor: 4.584

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.